Madrigal Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (5)

Latest Posts

About This Stock More About This Stock
Why Madrigal Pharma Boasts 133% Upside
Article By: TipRanks
Monday, November 19, 2018 8:23 AM EST
Earlier this month, Madrigal announced its Q3 earnings results, and the effect of the earlier stock offerings was clear. The company reported operating expenses of $11.3 million, R&D expenses of $6.2 million, and a $19.2 million cash burn.
In this article: MDGL
Read
5 Hot Stocks For The Second Quarter
Article By: TipRanks
Wednesday, March 28, 2018 9:40 AM EST
As the Q1 roller-coaster draws to a bumpy close, it’s time to move our attention to the coming quarter.
In this article: MTZ, MU, TGTX, FB, MDGL
Read
Madrigal Pharmaceuticals: What Is Going On?
Article By: Quad 7 Capital
Tuesday, March 13, 2018 12:51 PM EST
Madrigal Pharmaceuticals had an incredibly very productive 2017, what is more, 2018 looks to be equally transforming.
In this article: MDGL
Read
5 Top Multibagger Stocks To Buy In 2018
Article By: Zacks Investment Research
Tuesday, January 2, 2018 10:41 AM EST
By all measures, 2017 was a stellar year for U.S. stocks, with the Dow hitting several record highs and the S&P 500 closing at an eye-popping level of 2,700.
In this article: EGAN, BOOT, DAVE, CVRR, MDGL Also: WFC
Read
Madrigal Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, December 18, 2017 1:08 PM EST
Madrigal Pharmaceuticals, Inc., today announced that it has commenced an underwritten public offering of $100 million of its common stock.
In this article: MDGL
Read

PARTNER HEADLINES

Latest Tweets for $MDGL

No tweets yet!